Febre Maculosa

Febre maculosa, known in English as Brazilian spotted fever, is a severe and potentially fatal tick-borne infectious disease caused by the obligate intracellular bacterium Rickettsia rickettsii. This disease belongs to the spotted fever group of rickettsial infections and represents the same pathogen responsible for Rocky Mountain spotted fever in North America. The condition derives its Portuguese name from the characteristic macular skin rash that may develop in affected patients, though the rash is more consistently observed in humans than in dogs. In canine patients, the disease manifests primarily as a systemic vasculitis affecting blood vessels throughout the body, with the potential to cause severe multi-organ dysfunction and death if not recognized and treated promptly.

Rickettsia rickettsii is transmitted to dogs through the bite of infected ixodid ticks, with the primary vectors varying by geographic region. In Brazil and other parts of South America, the Amblyomma sculptum tick, formerly classified as Amblyomma cajennense, serves as the principal vector, while Amblyomma aureolatum is an important vector in the Atlantic Forest regions. In North America, the American dog tick Dermacentor variabilis, the Rocky Mountain wood tick Dermacentor andersoni, and the brown dog tick Rhipicephalus sanguineus are the primary vectors. Transmission typically requires several hours of tick attachment, during which the rickettsiae multiply within the tick's salivary glands before being injected into the host during feeding.

Once introduced into the dog's bloodstream, Rickettsia rickettsii demonstrates a specific tropism for vascular endothelial cells, the cells lining the inner surface of blood vessels throughout the body. The bacterium invades these cells and multiplies within the cytoplasm, eventually causing cell damage and death. This endothelial injury triggers a cascade of inflammatory responses, activation of the coagulation system, increased vascular permeability, and vasculitis that can affect vessels in virtually every organ system. The resulting vascular damage produces the diverse and often severe clinical manifestations that characterize the disease.

Febre maculosa holds significant public health importance because it is a zoonotic disease, meaning it can affect both animals and humans. While dogs do not directly transmit the infection to people, they serve as important sentinels for the presence of Rickettsia rickettsii in the environment and can bring infected ticks into close contact with their human family members. Outbreaks of febre maculosa in human populations have frequently been preceded by or associated with illness in dogs in the same geographic area, making canine surveillance an important component of public health monitoring in endemic regions.

Understanding the transmission cycle of Rickettsia rickettsii is essential for comprehending how dogs become infected with febre maculosa and for developing effective prevention strategies. The bacterium is maintained in nature through a complex cycle involving tick vectors, vertebrate reservoir hosts, and the environment. Ticks serve as both vectors and reservoirs of the pathogen, as Rickettsia rickettsii can be maintained within tick populations through transstadial transmission, in which the bacterium passes from one developmental stage of the tick to the next, and transovarial transmission, in which infected female ticks pass the organism to their offspring through their eggs.

The primary tick vectors involved in febre maculosa transmission vary by geographic region and ecological setting. In the cerrado and transitional biomes of southeastern Brazil, where the majority of human and canine cases occur, Amblyomma sculptum is the predominant vector. This three-host tick feeds on different animal species during each of its life stages, with larvae and nymphs commonly parasitizing small mammals and birds, while adults preferentially feed on larger mammals including horses, cattle, tapirs, capybaras, and dogs. The close association between Amblyomma sculptum populations and capybaras, which serve as amplifying hosts for Rickettsia rickettsii, creates epidemiological hotspots where transmission risk is particularly high.

Transmission of Rickettsia rickettsii from tick to dog requires a period of tick attachment during which the bacteria undergo a reactivation process within the tick's salivary glands. In unfed ticks, the rickettsiae exist in a dormant, avirulent state, but the stimulus of blood feeding triggers metabolic reactivation that restores virulence and initiates multiplication. This reactivation process typically requires a minimum of 6 to 10 hours of attachment, meaning that prompt removal of ticks from dogs significantly reduces the risk of transmission. However, this window may be shorter in ticks that have recently fed on another host, as the rickettsiae may already be in a reactivated state.

Dogs may also become exposed through ingestion of infected ticks during grooming behavior, though the relative importance of this oral route of transmission compared to bite transmission is not well established. Additionally, exposure to tick hemolymph during manual tick removal without gloves poses a theoretical risk to both dogs and their handlers, as crushing an infected tick can release rickettsiae that may enter through mucous membranes or breaks in the skin. Seasonal patterns of febre maculosa cases correlate with periods of peak tick activity, which vary by region but generally coincide with warmer, more humid months when tick populations are most abundant and actively seeking hosts.

Capybaras play a particularly critical role in the epidemiology of febre maculosa in Brazil. These large semi-aquatic rodents sustain high-level rickettsemia following infection, making them highly efficient amplifying hosts that can infect large numbers of feeding ticks. Urban expansion into areas inhabited by capybaras, combined with the animals' adaptability to human-modified environments such as parks, university campuses, and residential areas near waterways, has created new foci of transmission risk and contributed to the emergence of febre maculosa in periurban settings.

The clinical presentation of febre maculosa in dogs ranges from subclinical infection detected only through serological testing to fulminant, rapidly fatal disease with multi-organ failure. The severity of clinical illness depends on numerous factors including the virulence of the infecting Rickettsia rickettsii strain, the infectious dose, the dog's immune status, the rapidity of diagnosis and treatment initiation, and the presence of coinfections with other tick-borne pathogens. The incubation period, from tick bite to onset of clinical signs, typically ranges from 2 to 14 days.

Fever is usually the earliest clinical sign, often reaching 40 to 41 degrees Celsius or higher. The fever may be intermittent initially before becoming persistent as the infection progresses. Lethargy, depression, and anorexia accompany the fever and are often the first abnormalities noticed by dog owners. Muscle pain and joint stiffness may cause affected dogs to show reluctance to move, a stiff gait, or pain on palpation of the limbs and joints. These early, nonspecific signs can easily be attributed to many other conditions, contributing to diagnostic delays that allow the disease to progress.

As the vasculitis caused by rickettsial endothelial invasion becomes more widespread, clinical signs reflecting vascular damage in multiple organ systems emerge. Petechiae and ecchymoses, representing small and large areas of hemorrhage into the skin and mucous membranes, develop as damaged blood vessels leak red blood cells into surrounding tissues. These hemorrhagic lesions may be visible on the gums, conjunctivae, ear pinnae, ventral abdomen, and inguinal region. Epistaxis, hematuria, hematemesis, and melena reflect hemorrhage involving the nasal passages, urinary tract, and gastrointestinal system, respectively. The macular rash that gives the disease its name is more commonly observed in human patients and may be difficult to detect in dogs with pigmented skin or dense haircoats.

Neurological manifestations occur when vasculitis affects the blood vessels of the central nervous system, producing meningitis and encephalitis. Affected dogs may display altered mentation ranging from depression to stupor, vestibular signs including head tilt and nystagmus, ataxia, seizures, and in severe cases coma. Ocular involvement is common and may present as conjunctival hyperemia, anterior uveitis, retinal hemorrhages, and retinal vessel tortuosity visible on fundoscopic examination. Peripheral edema of the face, limbs, scrotum, or prepuce results from increased vascular permeability and may be a prominent early sign in some dogs.

In severe cases, the widespread endothelial damage and coagulopathy can progress to disseminated intravascular coagulation, a life-threatening condition in which simultaneous activation of coagulation and fibrinolysis leads to both widespread microvascular thrombosis and paradoxical hemorrhage. Acute kidney injury from renal vasculitis and hypoperfusion, acute respiratory distress syndrome from pulmonary vascular damage, and cardiovascular collapse from overwhelming vasodilation and fluid loss into tissues represent the most serious complications and are associated with the highest mortality rates. Dogs that progress to this stage of disease face a grave prognosis even with aggressive treatment.

Diagnosis of febre maculosa requires a high index of clinical suspicion, particularly in dogs from endemic areas presenting with acute febrile illness, thrombocytopenia, and evidence of vascular compromise. Because the early clinical signs are nonspecific and overlap with many other infectious and non-infectious conditions, laboratory testing is essential for confirming the diagnosis. Importantly, treatment should not be delayed while awaiting confirmatory test results in dogs with a compatible clinical presentation and epidemiological history, as early initiation of appropriate antibiotic therapy significantly improves outcomes.

Complete blood count findings in dogs with febre maculosa typically include thrombocytopenia, which may be severe, resulting from platelet consumption at sites of endothelial damage, sequestration in the spleen, and immune-mediated destruction. Mild to moderate anemia may develop as a consequence of hemorrhage and red blood cell destruction. The white blood cell count is variable, with some dogs showing leukopenia in the acute phase followed by leukocytosis as the immune response mounts, while others display leukocytosis throughout. A left shift with increased band neutrophils and toxic changes in neutrophils reflects the severity of the systemic inflammatory response.

Serum biochemistry abnormalities reflect the multi-organ effects of rickettsial vasculitis. Hypoalbuminemia develops as albumin is lost through damaged blood vessels into interstitial spaces and body cavities. Elevated hepatic enzyme activities, including alanine aminotransferase and alkaline phosphatase, indicate hepatocellular damage from hepatic vasculitis. Azotemia with elevated blood urea nitrogen and creatinine may be prerenal from dehydration and hypoperfusion, renal from direct vascular injury to the kidneys, or a combination of both. Hyponatremia, hypochloremia, and hypocalcemia are common electrolyte derangements. Coagulation testing may reveal prolonged prothrombin time and activated partial thromboplastin time with elevated fibrin degradation products, consistent with disseminated intravascular coagulation.

Serological testing using indirect immunofluorescence assay remains the reference standard for confirming Rickettsia rickettsii infection. A fourfold or greater rise in antibody titer between acute and convalescent serum samples collected 2 to 4 weeks apart provides definitive serological evidence of recent infection. A single elevated titer suggests exposure but cannot distinguish between current and past infection. The limitation of serology is the time required for antibody development, as dogs may not seroconvert for 7 to 14 days after the onset of clinical signs, meaning that acute-phase samples may be negative in dogs with early disease.

Polymerase chain reaction testing offers the advantage of detecting rickettsial DNA in blood or tissue samples during the acute phase of infection before antibodies have developed. PCR is highly specific but may have limited sensitivity in dogs that have already begun antibiotic therapy or in early infection when the rickettsemia is low. Direct immunofluorescence or immunohistochemistry on skin biopsy specimens from petechial lesions can demonstrate the presence of Rickettsia organisms within endothelial cells and provides rapid confirmation of the diagnosis when vasculitic skin lesions are present and accessible for biopsy.

Treatment of febre maculosa must be initiated as early as possible, as delays in starting appropriate antibiotic therapy are directly associated with increased morbidity and mortality. The cornerstone of treatment is doxycycline, a tetracycline antibiotic that achieves excellent intracellular concentrations and is highly effective against Rickettsia rickettsii. Doxycycline is administered at a dose of 5 milligrams per kilogram of body weight orally or intravenously every 12 hours, with the intravenous route preferred in dogs with severe disease, vomiting, or inability to tolerate oral medications. Treatment should continue for a minimum of 7 days and for at least 3 days beyond resolution of fever, whichever is longer.

Chloramphenicol represents an alternative antibiotic for cases where doxycycline cannot be used, though it is considered less effective and carries a higher risk of adverse effects including bone marrow suppression. Fluoroquinolones have demonstrated in vitro activity against some rickettsial species but are not considered reliable first-line agents for Rickettsia rickettsii infection and should not be substituted for doxycycline without compelling justification. The critical importance of early, appropriate antibiotic therapy cannot be overstated, as dogs treated within the first few days of illness generally respond rapidly, while those in which treatment is delayed until advanced disease has developed face significantly poorer outcomes.

Supportive care is essential for dogs with moderate to severe febre maculosa and may be as important as antibiotic therapy in determining survival. Aggressive intravenous fluid therapy is necessary to maintain tissue perfusion, support blood pressure, and promote renal function in the face of widespread vascular leakage and third-spacing of fluids. Crystalloid solutions are the primary fluids used, with the rate and volume adjusted based on the degree of dehydration, cardiovascular status, and urine output. Colloid support with synthetic colloids or plasma transfusion may be necessary in dogs with severe hypoalbuminemia and ongoing vascular leakage to maintain oncotic pressure and intravascular volume.

Management of coagulopathy and hemorrhage requires careful monitoring and targeted intervention. Platelet transfusions are generally not indicated for thrombocytopenia caused by rickettsial infection, as transfused platelets are rapidly consumed at sites of endothelial damage. Fresh frozen plasma provides coagulation factors that may be depleted in dogs with disseminated intravascular coagulation and is indicated when active hemorrhage is accompanied by prolongation of clotting times. Whole blood transfusion may be necessary in dogs with clinically significant anemia from hemorrhage. Heparin therapy for disseminated intravascular coagulation remains controversial and should be used judiciously under close monitoring.

Additional supportive measures include antiemetic therapy for dogs with persistent vomiting, gastroprotectant medications to reduce the risk of gastrointestinal hemorrhage from uremic or stress-related ulceration, oxygen supplementation or mechanical ventilation for dogs with respiratory compromise, and anticonvulsant therapy for dogs experiencing seizures from central nervous system vasculitis. Nutritional support through assisted feeding or parenteral nutrition should be initiated early in dogs unable to maintain voluntary food intake, as the catabolic state induced by severe systemic infection rapidly depletes energy reserves and compromises immune function.

The prognosis for dogs with febre maculosa is highly dependent on the rapidity of diagnosis and the timing of treatment initiation. Dogs that receive appropriate antibiotic therapy early in the disease course, typically within the first 2 to 5 days of clinical signs, generally demonstrate rapid improvement, with fever resolving within 24 to 72 hours of starting doxycycline and other clinical signs improving progressively over the following days. In these early-treated cases, the prognosis is good to excellent, with most dogs making a full recovery without lasting sequelae.

The prognosis becomes significantly more guarded in dogs that present with advanced disease or in which treatment is delayed beyond the first few days of illness. Dogs that have progressed to disseminated intravascular coagulation, acute kidney injury, acute respiratory distress syndrome, or severe neurological compromise face mortality rates that may exceed 50 percent even with aggressive intensive care. The severity of thrombocytopenia, the degree of azotemia, the presence of neurological signs, and the development of coagulopathy at presentation are all negative prognostic indicators that help predict the likelihood of survival.

Recovery in dogs with moderate to severe disease is typically gradual, requiring days to weeks of continued medical management and monitoring. Thrombocytopenia usually begins to resolve within 3 to 5 days of starting antibiotic therapy, though platelet counts may take longer to return to the normal range. Hepatic enzyme elevations and hypoalbuminemia gradually normalize as vascular integrity is restored and hepatocellular regeneration occurs. Renal function may recover partially or completely in dogs with acute kidney injury, depending on the severity and duration of renal vascular damage before treatment was initiated.

Neurological sequelae may persist in some dogs that experienced severe central nervous system involvement during the acute phase of infection. Vestibular dysfunction, behavioral changes, and visual impairment have been reported as residual effects in dogs recovering from rickettsial meningoencephalitis. Most of these neurological deficits improve over time with resolution of the inflammatory process, but complete recovery is not guaranteed in severely affected dogs. Follow-up neurological evaluation and serial monitoring of renal and hepatic function are recommended in the weeks to months following acute illness to document the extent of recovery and identify any persistent organ dysfunction that may require ongoing management.

Dogs that recover from febre maculosa develop immune responses that may provide some degree of protection against reinfection, though the duration and completeness of this immunity are not fully characterized. Recovered dogs remain at risk for reinfection if re-exposed to infected ticks, and continued tick prevention measures are essential for all dogs in endemic areas regardless of prior infection history.

Prevention of febre maculosa centers on minimizing the risk of tick exposure and ensuring rapid removal of any ticks that successfully attach to the dog. Comprehensive tick prevention programs combining environmental management, acaricidal treatments, and regular physical inspection of dogs provide the most effective protection against tick-borne rickettsial infections. In endemic areas where the risk of exposure to infected ticks is significant, rigorous adherence to prevention measures is essential for protecting both canine and human health.

Topical and systemic acaricidal products form the foundation of individual tick prevention in dogs. Isoxazoline-class oral medications, including fluralaner, afoxolaner, sarolaner, and lotilaner, provide excellent systemic tick-killing activity with convenient monthly or extended-duration dosing intervals. These products are absorbed into the dog's bloodstream and kill ticks that attach and begin feeding, typically within hours of attachment and often before the minimum attachment time required for Rickettsia transmission has elapsed. Topical spot-on products containing fipronil, permethrin, or other acaricides provide an additional or alternative option, with some products offering repellent activity that may prevent tick attachment altogether.

Acaricidal collars containing imidacloprid and flumethrin provide long-duration tick prevention and have demonstrated effectiveness in reducing tick attachment and disease transmission in field studies. Combining multiple prevention modalities, such as a systemic isoxazoline with a repellent collar, may provide enhanced protection in areas with high tick pressure, though veterinary guidance should be sought to ensure compatibility and avoid excessive chemical exposure. Regardless of the specific products chosen, year-round prevention is recommended in endemic areas, as tick activity may persist throughout the year in tropical and subtropical climates.

Environmental management to reduce tick habitat around homes and properties contributes to overall tick exposure reduction. Regular mowing of grass, removal of leaf litter and brush, creation of dry gravel or wood chip barriers between wooded areas and lawns, and management of wildlife that serve as tick hosts can reduce the density of questing ticks in the immediate vicinity of the home. In areas where capybara populations are present near residential areas, management of these amplifying hosts through population control or habitat modification may be necessary to reduce the risk of febre maculosa transmission, though such measures must be conducted within applicable wildlife management regulations.

Daily physical examination of dogs for attached ticks is an important supplemental prevention measure, particularly during periods of peak tick activity. Thorough inspection of the ears, face, neck, axillary regions, inguinal area, and between the toes, where ticks commonly attach, allows for early detection and removal of ticks before the minimum attachment time for rickettsial transmission has been reached. Ticks should be removed using fine-tipped forceps or a tick removal tool, grasping the tick as close to the skin surface as possible and applying steady upward traction without twisting or crushing the tick body. Hands should be protected with gloves during tick removal to prevent potential exposure to rickettsiae through contact with tick hemolymph.

Febre maculosa carries profound zoonotic significance as one of the most lethal tick-borne diseases affecting humans in the Americas. Rickettsia rickettsii causes identical disease in humans and dogs, and the case fatality rate in untreated human infections can exceed 20 to 40 percent, with even higher rates reported in some Brazilian outbreak settings. While dogs do not directly transmit the infection to humans through bites, saliva, or casual contact, they play several important indirect roles in the epidemiological chain that links the rickettsial pathogen to human disease.

Dogs serve as sentinel animals whose illness can provide early warning of Rickettsia rickettsii activity in the local tick population. Because dogs are frequently exposed to ticks in the peridomestic environment and develop clinical illness more rapidly than the epidemiological investigation of human cases can typically proceed, recognition of febre maculosa in dogs may alert public health authorities and veterinarians to an elevated risk of human infections in the same area. Serosurveys of dog populations in endemic areas have been used to map the geographic distribution of rickettsial activity and identify locations where human risk is highest.

The primary mechanism by which dogs contribute to human exposure is through their role as transport hosts for infected ticks. Dogs that roam in tick-infested habitats and return to the home environment can carry attached or semi-engorged ticks into close proximity with family members. Ticks that detach from dogs inside the home may subsequently seek human hosts, and the handling of tick-infested dogs provides opportunities for direct contact with infected ticks during grooming or petting. This transport host role underscores the importance of effective tick prevention on dogs as a measure that protects not only canine health but also the health of the human household.

In Brazil, febre maculosa is a nationally notifiable disease with significant public health surveillance infrastructure dedicated to monitoring its occurrence and implementing control measures during outbreaks. Veterinary professionals in endemic areas have a responsibility to report suspected cases of canine rickettsial disease to appropriate public health authorities and to educate dog owners about the zoonotic implications of tick-borne diseases. Clear communication about the importance of tick prevention, the signs of febre maculosa in both dogs and humans, and the need for prompt medical attention when tick-borne illness is suspected can contribute to earlier diagnosis and treatment of human cases.

The One Health concept, which recognizes the interconnection between animal health, human health, and environmental health, is particularly relevant to the management of febre maculosa. Effective control of this disease requires collaboration among veterinarians, physicians, public health officials, entomologists, and wildlife managers to address the multiple components of the transmission cycle. Integrated surveillance systems that combine data on human cases, canine infections, tick populations, and reservoir host dynamics provide the most comprehensive understanding of disease risk and the most effective basis for implementing targeted prevention and control measures.

Febre maculosa caused by Rickettsia rickettsii occurs throughout the Americas, with the geographic distribution of the disease determined by the range of competent tick vectors and the presence of reservoir and amplifying hosts. In Brazil, febre maculosa is concentrated in the southeastern states of Sao Paulo, Minas Gerais, Rio de Janeiro, and Espirito Santo, though cases have been reported from other states including Parana, Santa Catarina, and Bahia. The disease is particularly associated with areas where the overlap between Amblyomma sculptum tick habitat, capybara populations, and human or canine settlement creates conditions favorable for transmission.

The epidemiology of febre maculosa has been shaped by patterns of land use change, urbanization, and wildlife management. Deforestation and conversion of natural habitats to agricultural land have reduced populations of some natural tick hosts while favoring the expansion of capybara populations, which thrive in degraded landscapes with access to water and grazing areas. The establishment of capybara populations in urban and periurban parks, campuses, and residential areas adjacent to rivers and lakes has created new foci of febre maculosa transmission in settings where the disease was previously unknown, bringing the risk of infection into closer proximity with large human and dog populations.

Seasonal patterns of febre maculosa incidence reflect the activity cycles of the primary tick vectors. In southeastern Brazil, cases peak during the months of June through November, corresponding to the period when adult Amblyomma sculptum ticks are most actively seeking hosts. However, cases can occur year-round, as immature tick stages that may also transmit the pathogen are active during different seasons. In North America, where Rocky Mountain spotted fever is the equivalent disease, the peak season extends from April through September, coinciding with the activity period of Dermacentor variabilis and Dermacentor andersoni.

Seroepidemiological studies in dog populations within endemic areas have revealed that canine seroprevalence to Rickettsia rickettsii can be substantially higher than the apparent incidence of clinical disease, suggesting that subclinical or mild infections may be common. These findings indicate that many dogs are exposed to the organism without developing recognized illness, either because of infection with lower-virulence strains, partial immunity from prior exposure, or individual variation in host susceptibility. Nevertheless, the presence of seropositive dogs in a community serves as a reliable indicator of local rickettsial activity and justifies heightened vigilance for both canine and human disease.

The emergence of febre maculosa in new geographic areas and the intensification of transmission in established endemic zones represent an ongoing public health challenge in Brazil and other affected countries. Climate change, continued urbanization of natural landscapes, and increasing human and canine contact with tick-infested environments are expected to influence the future epidemiology of this disease. Continued surveillance, research into vector ecology and host-pathogen interactions, and development of improved diagnostic tools and prevention strategies are essential for mitigating the impact of febre maculosa on both animal and human populations.

For dog owners living in areas where febre maculosa is endemic, adopting a proactive and informed approach to tick-borne disease prevention is essential for protecting the health of both their canine companions and their human family members. This begins with understanding the local risk factors, including the seasonal patterns of tick activity, the presence of known reservoir hosts such as capybaras in the vicinity, and the specific tick species that are prevalent in the local environment. Veterinarians practicing in endemic areas should actively educate their clients about these risks and help them develop comprehensive prevention plans tailored to their specific circumstances.

Year-round tick prevention using veterinary-approved acaricidal products should be considered a non-negotiable component of responsible dog ownership in endemic regions. The cost of prevention products is negligible compared to the expense and heartache of treating a dog with advanced febre maculosa, to say nothing of the potential for fatal outcomes in both dogs and humans. Owners should work with their veterinarian to select the most appropriate prevention products for their dog based on factors including body weight, lifestyle, concurrent medications, and individual health considerations, and should adhere strictly to the recommended dosing schedule without gaps in coverage.

Modification of outdoor activities and environments can reduce tick exposure risk without requiring complete avoidance of outdoor enjoyment. Walking dogs on maintained trails and paths rather than through tall grass and underbrush reduces contact with questing ticks. Avoiding areas known to harbor large capybara populations during peak tick activity seasons is prudent when feasible. After outdoor excursions, thorough inspection of the dog for attached ticks followed by prompt removal of any found provides an additional layer of protection. Owners should also inspect themselves and other family members, as the same tick habitats that expose dogs to infected ticks also pose risks to humans.

Knowing the early signs of febre maculosa in dogs and seeking immediate veterinary attention when they appear can be life-saving. Owners in endemic areas should be educated to recognize that unexplained fever, lethargy, loss of appetite, and particularly the combination of these signs with petechial hemorrhages on the gums or skin warrants emergency veterinary evaluation. Mentioning the possibility of tick-borne disease to the veterinarian and reporting any known or suspected tick exposure helps ensure that appropriate diagnostic testing and empiric antibiotic therapy are initiated without delay.

Community-level engagement in febre maculosa prevention strengthens the protective effect of individual efforts. Supporting local mosquito and tick control programs, participating in public health surveillance initiatives, advocating for responsible management of capybara populations in urban settings, and sharing knowledge about tick-borne disease prevention with neighbors and fellow dog owners all contribute to reducing the collective burden of febre maculosa in endemic communities. The interconnected nature of this zoonotic disease means that efforts to protect dogs from infection simultaneously protect human health, reinforcing the principle that the well-being of animals and people are fundamentally linked.